S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT

• Mark Hartmann,
• Maximilian Schönung,
• Jovana Rajak,
• Joschka Hey,
• Valentin Maurer,
• Ling Hai,
• Sina Staeble,
• Jens Langstein,
• Katharina Bauer,
• Mariam Hakobyan,
• Laura Jardine,
• Sheila Bohler,
• Dominik Vonficht,
• Abdul-Habib Maag,
• Dirk Lebrecht,
• Kathrin Bernt,
• Roland Rölz,
• Tobias Boch,
• Eleonora Khabirova,
• Pavlo Lutsik,
• Simon Haas,
• Muzlifah Haniffa,
• Sam Behjati,
• Jan-Philipp Mallm,
• Christian Buske,
• Michael Milsom,
• Stefan Fröhling,
• Marc-Jan Bonder,
• Christoph Plass,
• Charlotte Niemeyer,
• Christian Flotho,
• Miriam Erlacher,
• Matthias Schlesner,
• Daniel B. Lipka

Affiliations

Mark Hartmann

1 German Cancer Research Center (DKFZ), Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, Heidelberg, Germany

Maximilian Schönung

1 German Cancer Research Center (DKFZ), Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, Heidelberg, Germany

Jovana Rajak

3 University of Freiburg, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, Freiburg, Germany

Joschka Hey

4 German Cancer Research Center (DKFZ), Division of Cancer Epigenomics, Heidelberg, Germany

Valentin Maurer

1 German Cancer Research Center (DKFZ), Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, Heidelberg, Germany

Ling Hai

5 University Hospital Heidelberg, Department of Neurology and Neurooncology, Heidelberg, Germany

Sina Staeble

1 German Cancer Research Center (DKFZ), Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, Heidelberg, Germany

Jens Langstein

1 German Cancer Research Center (DKFZ), Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, Heidelberg, Germany

Katharina Bauer

6 German Cancer Research Center (DKFZ), scOPEN Lab, Heidelberg, Germany

Mariam Hakobyan

1 German Cancer Research Center (DKFZ), Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, Heidelberg, Germany

Laura Jardine

8 Newcastle University, Biosciences Institute, Newcastle upon Tyne, United Kingdom

Sheila Bohler

3 University of Freiburg, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, Freiburg, Germany

Dominik Vonficht

7 Heidelberg University, Faculty of Biosciences, Heidelberg, Germany

Abdul-Habib Maag

12 University Hospital of Ulm, Institute of Experimental Cancer Research, Ulm, Germany

Dirk Lebrecht

3 University of Freiburg, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, Freiburg, Germany

Kathrin Bernt

14 Children’s Hospital of Philadelphia, Division of Pediatric Oncology, Philadelphia, United States

Roland Rölz

15 University of Freiburg, Department of Neurosurgery, Faculty of Medicine, Medical Center, Freiburg, Germany

Tobias Boch

16 Heidelberg University, Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany

Eleonora Khabirova

17 Wellcome Sanger Institute, Hinxton, United Kingdom

Pavlo Lutsik

4 German Cancer Research Center (DKFZ), Division of Cancer Epigenomics, Heidelberg, Germany

Simon Haas

9 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany

Muzlifah Haniffa

8 Newcastle University, Biosciences Institute, Newcastle upon Tyne, United Kingdom

Sam Behjati

17 Wellcome Sanger Institute, Hinxton, United Kingdom

Jan-Philipp Mallm

6 German Cancer Research Center (DKFZ), scOPEN Lab, Heidelberg, Germany

Christian Buske

12 University Hospital of Ulm, Institute of Experimental Cancer Research, Ulm, Germany

Michael Milsom

9 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany

Stefan Fröhling

2 National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany

Marc-Jan Bonder

22 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, United Kingdom

Christoph Plass

4 German Cancer Research Center (DKFZ), Division of Cancer Epigenomics, Heidelberg, Germany

Charlotte Niemeyer

3 University of Freiburg, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, Freiburg, Germany

Christian Flotho

3 University of Freiburg, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, Freiburg, Germany

Miriam Erlacher

3 University of Freiburg, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, Freiburg, Germany

Matthias Schlesner

25 Augsburg University, Faculty of Applied Computer Sciences, Biomedical Informatics, Data Mining and Data Analytics, Augsburg, Germany

Daniel B. Lipka

1 German Cancer Research Center (DKFZ), Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, Heidelberg, Germany